Aspects of statin prescribing in Norwegian counties with high, average and low statin consumption – an individual-level prescription database study
Open Access
- 5 December 2007
- journal article
- research article
- Published by Springer Nature in BMC Clinical Pharmacology
- Vol. 7 (1) , 14
Abstract
A previous study has shown that variations in threshold and intensity (lipid goal attainment) of statins for primary prevention contribute to regional differences in overall consumption of statins in Norway. Our objective was to explore how differences in prevalences of use, dosing characteristics, choice of statin and continuity of therapy in individual patients adds new information to previous results.Keywords
This publication has 17 references indexed in Scilit:
- Why do sales of lipid-lowering drugs vary between counties in Norway?Scandinavian Journal of Primary Health Care, 2006
- Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statinsThe Lancet, 2005
- Trends in prescribing and utilization of statins and other lipid lowering drugs across Europe 1997–2003British Journal of Clinical Pharmacology, 2005
- Whom are we treating with lipid-lowering drugs? Are we following the guidelines? Evidence from a population-based study: the Troms study 2001European Journal of Clinical Pharmacology, 2004
- Undertreatment and overtreatment with statins: the Oslo Health Study 2000–2001Journal of Internal Medicine, 2004
- Quality of lipid‐lowering therapy in patients with ischaemic heart disease: a register‐based study in 3477 patientsJournal of Internal Medicine, 2004
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialThe Lancet, 2002
- Time trends in lipid lowering drug use in The Netherlands. Has the backlog of candidates for treatment been eliminated?British Journal of Clinical Pharmacology, 2002
- Use of lipid‐lowering drugs during 1991–98 in Northern Jutland, DenmarkBritish Journal of Clinical Pharmacology, 2001
- Changes in the utilisation of lipid-lowering drugs over a 6-year period (1993-1998) in a Danish population.European Journal of Clinical Pharmacology, 2001